Advertisement

Cell and Tissue Research

, Volume 377, Issue 1, pp 21–43 | Cite as

The molecular neurobiology of chronic pain–induced depression

  • Muris Humo
  • Han Lu
  • Ipek YalcinEmail author
Review

Abstract

The increasing number of individuals with comorbidities poses an urgent need to improve the management of patients with multiple co-existing diseases. Among these comorbidities, chronic pain and mood disorders, two long-lasting disabling conditions that significantly reduce the quality of life, could be cited first. The recent development of animal models accelerated the studies focusing on the underlying mechanisms of the chronic pain and depression/anxiety comorbidity. This review provides an overview of clinical and pre-clinical studies performed over the past two decades addressing the molecular aspects of the comorbid relationship of chronic pain and depression. We thus focused on the studies that investigated the molecular characteristics of the comorbid relationship between chronic pain and mood disorders, especially major depressive disorders, from the genetic and epigenetic point of view to key neuromodulators which have been shown to play an important role in this comorbidity.

Keywords

Chronic pain Depression Molecular characteristics Behavior Neuropathic pain 

Notes

Funding information

This work was supported by the Centre National de la Recherche Scientifique (contract UPR3212), the University of Strasbourg, the Neurex Doctorate fellow, NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation (24736), Fondation pour la Recherche Médicale (FRM FDT201805005527), French National Research Agency (ANR) through the Programme d’Investissement d’Avenir under the contract ANR-17-EURE-0022.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. Alba-Delgado C, Llorca-Torralba M, Horrillo I, Ortega JE, Mico JA, Sánchez-Blázquez P, Meana JJ, Berrocoso E (2013) Chronic pain leads to concomitant noradrenergic impairment and mood disorders. Biol Psychiatry 73:54–62Google Scholar
  2. Alba-Delgado C, Cebada-Aleu A, Mico JA, Berrocoso E (2016) Comorbid anxiety-like behavior and locus coeruleus impairment in diabetic peripheral neuropathy: a comparative study with the chronic constriction injury model. Prog Neuro-Psychopharmacol Biol Psychiatry 71:45–56Google Scholar
  3. Alexander GM, Van Rijn MA, Van Hilten JJ, Perreault MJ, Schwartzman RJ (2005) Changes in cerebrospinal fluid levels of pro-inflammatory cytokines in CRPS. Pain 116:213–219Google Scholar
  4. Almeida C, DeMaman A, Kusuda R, Cadetti F, Ravanelli MI, Queiroz AL, Sousa TA, Zanon S, Silveira LR, Lucas G (2015) Exercise therapy normalizes BDNF upregulation and glial hyperactivity in a mouse model of neuropathic pain. Pain 156:504–513Google Scholar
  5. Apkarian AV, Lavarello S, Randolf A, Berra HH, Chialvo DR, Besedovsky HO, del Rey A (2006) Expression of IL-1β in supraspinal brain regions in rats with neuropathic pain. Neurosci Lett 407:176–181Google Scholar
  6. Arora V, Chopra K (2013) Possible involvement of oxido-nitrosative stress induced neuro-inflammatory cascade and monoaminergic pathway: underpinning the correlation between nociceptive and depressive behaviour in a rodent model. J Affect Disord 151:1041–1052Google Scholar
  7. Arora V, Kuhad A, Tiwari V, Chopra K (2011) Curcumin ameliorates reserpine-induced pain–depression dyad: behavioural, biochemical, neurochemical and molecular evidences. Psychoneuroendocrinology 36:1570–1581Google Scholar
  8. Attal N, Lanteri-Minnet M, Laurent B, Fermanian J, Bouhassira D (2011) The specific disease burden of neuropathic pain: results of a French nationwide survey. Pain 152:2836–2843Google Scholar
  9. Avila-Martin G, Galan-Arriero I, Ferrer-Donato A, Busquets X, Gomez-Soriano J, Escribá PV, Taylor J (2015) Oral 2-hydroxyoleic acid inhibits reflex hypersensitivity and open-field-induced anxiety after spared nerve injury. Eur J Pain 19:111–122Google Scholar
  10. Bair MJ, Robinson RL, Katon W, Kroenke K (2003) Depression and pain comorbidity: a literature review. Arch Intern Med 163:2433–2445Google Scholar
  11. Barrot M (2012) Tests and models of nociception and pain in rodent. Neuroscience 211:39–50Google Scholar
  12. Barthas F, Humo M, Gilsbach R, Waltisperger E, Karatas M, Leman S, Hein L, Belzung C, Boutillier AL, Barrot M, Yalcin I (2017) Cingulate overexpression of mitogen-activated protein kinase phosphatase-1 as a key factor for depression. Biol Psychiatry 82:370–379Google Scholar
  13. Benbouzid M, Pallage V, Rajalu M, Waltisperger E, Doridot S, Poisbeau P, Freund-Mercier MJ, Barrot M (2008) Sciatic nerve cuffing in mice: a model of sustained neuropathic pain. Eur J Pain 12:591–599Google Scholar
  14. Benson C, Mifflin K, Kerr B, Jesudasan SJB, Dursun S, Baker G (2015) Biogenic amines and the amino acids GABA and glutamate: relationships with pain and depression. Mod Trends Pharmacopsychiatry 30:67–79Google Scholar
  15. Berger SL (2007) The complex language of chromatin regulation during transcription. Nature 447:407–412Google Scholar
  16. Bomholt SF, Mikkelsen JD, Blackburn-Munro G (2005) Normal hypothalamo-pituitary-adrenal axis function in a rat model of peripheral neuropathic pain. Brain Res 1044:216–226Google Scholar
  17. Bozzini S, Gambelli P, Boiocchi C, Schirinzi S, Falcone R, Buzzi P, Storti C, Falcone C (2009) Coronary artery disease and depression: possible role of brain-derived neurotrophic factor and serotonin transporter gene polymorphisms. Int J Mol Med 24:813–818Google Scholar
  18. Bramham CR, Messaoudi E (2005) BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis. Prog Neurobiol 76:99–125Google Scholar
  19. Bravo L, Alba-Delgado C, Torres-Sanchez S, Mico JA, Neto FL, Berrocoso E (2013) Social stress exacerbates the aversion to painful experiences in rats exposed to chronic pain: the role of the locus coeruleus. Pain 154:2014–2023Google Scholar
  20. Bravo L, Torres-Sanchez S, Alba-Delgado C, Mico JA, Berrocoso E (2014) Pain exacerbates chronic mild stress-induced changes in noradrenergic transmission in rats. Eur Neuropsychopharmacol 24:996–1003Google Scholar
  21. Bromet E, Andrade LH, Hwang I, Sampson NA, Alonso J, de Girolamo G, de Graaf R, Demyttenaere K, Hu C, Iwata N, Karam AN, Kaur J, Kostyuchenko S, Lepine JP, Levinson D, Matschinger H, Mora MEM, Browne MO, Posada-Villa J, Viana MC, Williams DR, Kessler R (2011) Cross national epidemiology of DSM-IV major depressive episode. BMC Med 9:90Google Scholar
  22. Brown JP, Couillard-Després S, Cooper-Kuhn CM, Winkler J, Aigner L, Kuhn HG (2003) Transient expression of doublecortin during adult neurogenesis. J Comp Neurol 467:1–10Google Scholar
  23. Brüning CA, Martini F, Soares SM, Sampaio TB, Gai BM, Duarte MM, Nogueira CW (2015) M-Trifluoromethyl-diphenyl diselenide, a multi-target selenium compound, prevented mechanical allodynia and depressive-like behavior in a mouse comorbid pain and depression model. Prog Neuro-Psychopharmacol Biol Psychiatry 63:35–46Google Scholar
  24. Bura AS, Guegan T, Zamanillo D, Vela JM, Maldonado R (2013) Operant self-administration of a sigma ligand improves nociceptive and emotional manifestations of neuropathic pain. Eur J Pain 17:832–843Google Scholar
  25. Burke NN, Geoghegan E, Kerr DM, Moriarty O, Finn DP, Roche M (2013a) Altered neuropathic pain behaviour in a rat model of depression is associated with changes in inflammatory gene expression in the amygdala. Genes Brain Behav 12:705–713Google Scholar
  26. Burke NN, Llorente R, Marco EM, Tong K, Finn DP, Viveros MP, Roche M (2013b) Maternal deprivation is associated with sex-dependent alterations in nociceptive behavior and neuroinflammatory mediators in the rat following peripheral nerve injury. J Pain 14:1173–1184Google Scholar
  27. Burke NN, Finn DP, Roche M (2015a) Neuroinflammatory mechanisms linking pain and depression. Mod Trends Pharmacopsychiatry 30:36–50Google Scholar
  28. Burke NN, Finn DP, Roche M (2015b) Chronic administration of amitriptyline differentially alters neuropathic pain-related behaviour in the presence and absence of a depressive-like phenotype. Behav Brain Res 278:193–201Google Scholar
  29. Burri A, Ogata S, Livshits G, Williams F (2015) The association between chronic widespread musculoskeletal pain, depression and fatigue is genetically mediated. PLoS One 10:e0140289Google Scholar
  30. Capuron L, Miller AH (2011) Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol Ther 130(2):226–238Google Scholar
  31. Caspani O, Reitz MC, Ceci A, Kremer A, Treede RD (2014) Tramadol reduces anxiety-related and depression-associated behaviors presumably induced by pain in the chronic constriction injury model of neuropathic pain in rats. Pharmacol Biochem Behav 124:290–296Google Scholar
  32. Chiechio S (2016) Modulation of chronic pain by metabotropic glutamate receptors. Adv Pharmacol 75:63–89Google Scholar
  33. Chiechio S, Copani A, De Petris L, Morales ME, Nicoletti F, Gereau RW 4th (2006) Transcriptional regulation of metabotropic glutamate receptor 2/3 expression by the NF-kappaB pathway in primary dorsal root ganglia neurons: a possible mechanism for the analgesic effect of L-acetylcarnitine. Mol Pain 2:20Google Scholar
  34. Chung G, Kim CY, Yun YC, Yoon SH, Kim MH, Kim YK, Kim SJ (2017) Upregulation of prefrontal metabotropic glutamate receptor 5 mediates neuropathic pain and negative mood symptoms after spinal nerve injury in rats. Sci Rep 7:9743Google Scholar
  35. Clark AK, Old EA, Malcangio M (2013) Neuropathic pain and cytokines: current perspectives. J Pain Res 6:803–814Google Scholar
  36. Conte A, Khan N, Defazio G, Rothwell JC, Berardelli A (2013) Pathophysiology of somatosensory abnormalities in Parkinson disease. Nat Rev Neurol 9:687–697Google Scholar
  37. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9(1):46–56Google Scholar
  38. del Rey A, Yau HJ, Randolf A, Centeno MV, Wildmann J, Martina M, Besedovsky HO, Apkarian AV (2011) Chronic neuropathic pain-like behavior correlates with IL-1β expression and disrupts cytokine interactions in the hippocampus. Pain 152:2827–2835Google Scholar
  39. Dellarole A, Morton P, Brambilla R, Walters W, Summers S, Bernardes D, Grilli M, Bethea JR (2014) Neuropathic pain-induced depressive-like behavior and hippocampal neurogenesis and plasticity are dependent on TNFR1 signaling. Brain Behav Immun 41:65–81Google Scholar
  40. Descalzi G, Ikegami D, Ushijima T, Nestler EJ, Zachariou V, Narita M (2015) Epigenetic mechanisms of chronic pain. Trends Neurosci 38:237–246Google Scholar
  41. Descalzi G, Mitsi V, Purushothaman I, Gaspari S, Avrampou K, Loh YE, Shen L, Zachariou V (2017) Neuropathic pain promotes adaptive changes in gene expression in brain networks involved in stress and depression. Sci Signal 10.  https://doi.org/10.1126/scisignal.aaj1549
  42. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:1946–1949Google Scholar
  43. Dimitrov EL, Tsuda MC, Cameron HA, Usdin TB (2014) Anxiety- and depression-like behavior and impaired neurogenesis evoked by peripheral neuropathy persist following resolution of prolonged tactile hypersensitivity. J Neurosci 34:12304–12312Google Scholar
  44. Donovan MJ, Lin MI, Wiegn P, Ringstedt T, Kraemer R, Hahn R, Wang S, Ibañez CF, Rafii S, Hempstead BL (2000) Brain derived neurotrophic factor is an endothelial cell survival factor required for intramyocardial vessel stabilization. Development 127:4531–4540Google Scholar
  45. Dragunow M, Faull R (1989) The use of c-fos as a metabolic marker in neuronal pathway tracing. J Neurosci Methods 29:261–265Google Scholar
  46. Duric V, McCarson KE (2006) Effects of analgesic or antidepressant drugs on pain-or stress-evoked hippocampal and spinal neurokinin-1 receptor and brain-derived neurotrophic factor gene expression in the rat. J Pharmacol Exp Ther 319:1235–1243Google Scholar
  47. Duric V, McCarson KE (2007) Neurokinin-1 (NK-1) receptor and brain-derived neurotrophic factor (BDNF) gene expression is differentially modulated in the rat spinal dorsal horn and hippocampus during inflammatory pain. Mol Pain 3:32Google Scholar
  48. Ettensohn MF, Markey SM, Levine SP (2018) Considering ketamine for treatment of comorbid pain, depression, and substance use disorders. Psychiatr Ann 48:180–183Google Scholar
  49. Feyissa AM, Woolverton WL, Miguel-Hidalgo JJ, Wang Z, Kyle PB, Hasler G, Stockmeier CA, Iyo AH, Karolewicz B (2010) Elevated level of metabotropic glutamate receptor 2/3 in the prefrontal cortex in major depression. Prog Neuro-Psychopharmacol Biol Psychiatry 34:279–283Google Scholar
  50. Fitzgibbon M, Finn DP, Roche M (2015) High times for painful blues: the endocannabinoid system in pain-depression comorbidity. Int J Neuropsychopharmacol 19:1–20Google Scholar
  51. Fukuhara K, Ishikawa K, Yasuda S, Kishishita Y, Kim HK, Kakeda T, Yamamoto M, Norii T, Ishikawa T (2012) Intracerebroventricular 4-methylcatechol (4-MC) ameliorates chronic pain associated with depression-like behavior via induction of brain-derived neurotrophic factor (BDNF). Cell Mol Neurobiol 32:971–977Google Scholar
  52. Gai BM, Bortolatto CF, Brüning CA, Zborowski VA, Stein AL, Zeni G, Nogueira CW (2014) Depression-related behavior and mechanical allodynia are blocked by 3-(4-fluorophenylselenyl)-2,5-diphenylselenophene in a mouse model of neuropathic pain induced by partial sciatic nerve ligation. Neuropharmacology 79:580–589Google Scholar
  53. Galan-Arriero I, Avila-Martin G, Ferrer-Donato A, Gomez-Soriano J, Bravo-Esteban E, Taylor J (2014) Oral administration of the p38alpha MAPK inhibitor, UR13870, inhibits affective pain behavior after spinal cord injury. Pain 155:2188–2198Google Scholar
  54. Gaoni Y, Mechoulam R (1964) Isolation, structure, and partial synthesis of an active constituent of hashish. J Am Chem Soc 86:1646Google Scholar
  55. Gasperi M, Herbert M, Schur E, Buchwald D, Afari N (2017) Genetic and environmental influences on sleep, pain, and depression symptoms in a community sample of twins. Psychosom Med 79:646–654Google Scholar
  56. Generaal E, Vogelzangs N, Macfarlane GJ, Geenen R, Smit JH, Penninx BW, Dekker J (2014) Reduced hypothalamic-pituitary-adrenal axis activity in chronic multi-site musculoskeletal pain: partly masked by depressive and anxiety disorders. BMC Musculoskelet Disord 15:227Google Scholar
  57. Generaal E, Milaneschi Y, Jansen R, Elzinga BM, Dekker J, Penninx BW (2016) The brain-derived neurotrophic factor pathway, life stress, and chronic multi-site musculoskeletal pain. Mol Pain 4:12Google Scholar
  58. Goffer Y, Xu D, Eberle SE, D’amour J, Lee M, Tukey D, Froemke RC, Ziff EB, Wang J (2013) Calcium-permeable AMPA receptors in the nucleus accumbens regulate depression-like behaviors in the chronic neuropathic pain state. J Neurosci 33:19034–19044Google Scholar
  59. Goldenberg DL, Clauw DJ, Palmer RH, Mease P, Chen W, Gendreau RM (2010) Durability of therapeutic response to milnacipran treatment for fibromyalgia. Results of a randomized, double-blind, monotherapy 6-month extension study. Pain Med 11:180–194Google Scholar
  60. Gonçalves L, Silva R, Pinto-Ribeiro F, Pêgo JM, Bessa JM, Pertovaara A, Sousa N, Almeida A (2008) Neuropathic pain is associated with depressive behaviour and induces neuroplasticity in the amygdala of the rat. Exp Neurol 213:48–56Google Scholar
  61. González-Sepúlveda M, Pozo OJ, Marcos J, Valverde O (2016) Chronic pain causes a persistent anxiety state leading to increased ethanol intake in CD1 mice. J Psychopharmacol 30:188–203Google Scholar
  62. Gregoire S, Michaud V, Chapuy E, Eschalier A, Ardid D (2012) Study of emotional and cognitive impairments in mononeuropathic rats: effect of duloxetine and gabapentin. Pain 153:1657–1663Google Scholar
  63. Grilli M (2017) Chronic pain and adult hippocampal neurogenesis: translational implications from preclinical studies. J Pain Res 10:2281–2286Google Scholar
  64. Gui WS, Wei X, Mai CL, Murugan M, Wu LJ, Xin WJ, Zhou LJ, Liu XG (2016) Interleukin-1β overproduction is a common cause for neuropathic pain, memory deficit, and depression following peripheral nerve injury in rodents. Mol Pain 12.  https://doi.org/10.1177/1744806916646784
  65. Guiard BP, El Mansari M, Blier P (2009) Prospect of a dopamine contribution in the next generation of antidepressant drugs: the triple reuptake inhibitors. Curr Drug Targets 10:1069–1084Google Scholar
  66. Guida F, Luongo L, Marmo F, Romano R, Iannotta M, Napolitano F, Belardo C, Marabese I, D’Aniello A, De Gregorio D, Rossi F, Piscitelli F, Lattanzi R, de Bartolomeis A, Usiello A, Di Marzo V, de Novellis V, Maione S (2015) Palmitoylethanolamide reduces pain-related behaviors and restores glutamatergic synapses homeostasis in the medial prefrontal cortex of neuropathic mice. Mol Pain 8:47Google Scholar
  67. Haas L, Portela LV, Boehmer AE, Oses JP, Lara DR (2010) Increased plasma levels of brain derived neurotrophic factor (BDNF) in patients with fibromyalgia. Neurochem Res 35:830–834Google Scholar
  68. Haase J, Brown E (2015) Integrating the monoamine, neurotrophin and cytokine hypotheses of depression--a central role for the serotonin transporter? Pharmacol Ther 147:1–11Google Scholar
  69. Hache G, Coudore F, Gardier AM, Guiard BP (2011) Monoaminergic antidepressants in the relief of pain: potential therapeutic utility of triple reuptake inhibitors (TRIs). Pharmaceuticals (Basel) 4:285–342Google Scholar
  70. Hache G, Guiard BP, Nguyen TH, Quesseveur G, Gardier AM, Peters D, Munro G, Coudoré F (2015) Antinociceptive activity of the new triple reuptake inhibitor NS18283 in a mouse model of chemotherapy-induced neuropathic pain. Eur J Pain 19:322–333Google Scholar
  71. Hanson ND, Owens MJ, Nemeroff CB (2011) Depression, antidepressants, and neurogenesis: a critical reappraisal. Neuropsychopharmacology 36:2589–2602Google Scholar
  72. Hasnie FS, Breuer J, Parker S, Wallace V, Blackbeard J, Lever I, Kinchington PR, Dickenson AH, Pheby T, Rice AS (2007) Further characterization of a rat model of varicella zoster virus-associated pain: relationship between mechanical hypersensitivity and anxiety-related behavior, and the influence of analgesic drugs. Neuroscience 144:1495–1508Google Scholar
  73. Häuser W, Arnold B, Eich W, Felde E, Flügge C, Henningsen P, Herrmann M, Köllner V, Kühn E, Nutzinger D, Offenbächer M, Schiltenwolf M, Sommer C, Thieme K, Kopp I (2008) Management of fibromyalgia syndrome--an interdisciplinary evidence-based guideline. Ger Med Sci 6:Doc14Google Scholar
  74. Hoeffler JP, Habener JF (1990) Characterization of a cyclic AMP regulatory element DNA-binding protein. Trends Endocrinol Metab 1:155–158Google Scholar
  75. Hofer M, Pagliusi SR, Hohn A, Leibrock J, Barde YA (1990) Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain. EMBO J 9:2459–2464Google Scholar
  76. Hoffman GE, Smith MS, Verbalis JG (1993) C-Fos and related immediate early gene products as markers of activity in neuroendocrine systems. Front Neuroendocrinol 14:173–213Google Scholar
  77. Hosang GM, Shiles C, Tansey KE, McGuffin P, Uher R (2014) Interaction between stress and the BDNF Val66Met polymorphism in depression: a systematic review and meta-analysis. BMC Med 12:7Google Scholar
  78. Hu B, Doods H, Treede RD, Ceci A (2009) Depression-like behavior in rats with mononeuropathy is reduced by the CB2-selective agonist GW405833. Pain 143:206–212Google Scholar
  79. Hu Y, Yang J, Hu Y, Wang Y, Li W (2010) Amitriptyline rather than lornoxicam ameliorates neuropathic pain-induced deficits in abilities of spatial learning and memory. Eur J Anaesthesiol 27:162–116Google Scholar
  80. Hu C, Yang H, Zhao Y, Chen X, Dong Y, Li L, Dong Y, Cui J, Zhu T, Zheng P, Lin CS, Dai J (2016) The role of inflammatory cytokines and ERK1/2 signaling in chronic prostatitis/chronic pelvic pain syndrome with related mental health disorders. Sci Rep 6:28608Google Scholar
  81. Ishikawa K, Yasuda S, Fukuhara K, Iwanaga Y, Ida Y, Ishikawa J, Yamagata H, Ono M, Kakeda T, Ishikawa T (2014) 4-Methylcatechol prevents derangements of brain-derived neurotrophic factor and TrkB-related signaling in anterior cingulate cortex in chronic pain with depression-like behavior. Neuroreport 25:226–232Google Scholar
  82. Ji G, Fu Y, Ruppert KA, Neugebauer V (2007) Pain-related anxiety-like behavior requires CRF1 receptors in the amygdala. Mol Pain 3:13Google Scholar
  83. Jiang X, Yan Q, Liu F, Jing C, Ding L, Zhang L, Pang C (2018) Chronic trans-astaxanthin treatment exerts antihyperalgesic effect and corrects co-morbid depressive like behaviors in mice with chronic pain. Neurosci Lett 662:36–43Google Scholar
  84. Jo KB, Lee YJ, Lee IG, Lee SC, Park JY, Ahn RS (2016) Association of pain intensity, pain-related disability, and depression with hypothalamus-pituitary-adrenal axis function in female patients with chronic temporomandibular disorders. Psychoneuroendocrinology 69:106–115Google Scholar
  85. Kato T, Ide S, Minami M (2016) Pain relief induces dopamine release in the rat nucleus accumbens during the early but not late phase of neuropathic pain. Neurosci Lett 629:73–78Google Scholar
  86. Kelly CJ, Huang M, Meltzer H, Martina M (2016) Reduced glutamatergic currents and dendritic branching of layer 5 pyramidal cells contribute to medial prefrontal cortex deactivation in a rat model of neuropathic pain. Front Cell Neurosci 10:133Google Scholar
  87. Kilburn-Watt E, Banati RB, Keay KA (2010) Altered thyroid hormones and behavioural change in a sub-population of rats following chronic constriction injury. J Neuroendocrinol 22:960–970Google Scholar
  88. Kim H, Chen L, Lim G, Sung B, Wang S, McCabe MF, Rusanescu G, Yang L, Tian Y, Mao J (2012) Brain indoleamine 2,3- dioxygenase contributes to the comorbidity of pain and depression. J Clin Invest 122:2940–2954Google Scholar
  89. Kodama D, Ono H, Tanabe M (2011) Increased hippocampal glycine uptake and cognitive dys-function after peripheral nerve injury. Pain 152:809–817Google Scholar
  90. Koga K, Descalzi G, Chen T, Ko HG, Lu J, Li S, Son J, Kim T, Kwak C, Huganir RL, Zhao MG, Kaang BK, Collingridge GL, Zhuo M (2015) Coexistence of two forms of LTP in ACC provides a synaptic mechanism for the interactions between anxiety and chronic pain. Neuron 85:377–389Google Scholar
  91. Kontinen VK, Kauppila T, Paananen S, Pertovaara A, Kalso E (1999) Behavioural measures of depression and anxiety in rats with spinal nerve ligation-induced neuropathy. Pain 80:341–346Google Scholar
  92. La Porta C, Bura AS, Llorente-Onaindia J, Pastor A, Navarrete F, Garcia-Gutierrez MS, De la Torre R, Manzanares J, Monfort J, Maldonado R (2015) Role of the endocannabinoid system in the emotional manifestations of osteoarthritis pain. Pain 156(10):2001–2012Google Scholar
  93. La Porta C, Lara-Mayorga IM, Negrete R, Maldonado R (2016) Effects of pregabalin on the nociceptive, emotional and cognitive manifestations of neuropathic pain in mice. Eur J Pain 20:1454–1466Google Scholar
  94. Le AM, Lee M, Su C, Zou A, Wang J (2014) AMPAkines have novel analgesic properties in rat models of persistent neuropathic and inflammatory pain. Anesthesiology 121:1080–1090Google Scholar
  95. Lebe M, Hasenbring MI, Schmieder K, Jetschke K, Harders A, Epplen JT, Hoffjan S, Kötting J (2013) Association of serotonin-1A and -2A receptor promoter polymorphisms with depressive symptoms, functional recovery, and pain in patients 6 months after lumbar disc surgery. Pain 154:377–438Google Scholar
  96. Lee YH, Choi SJ, Ji JD, Song GG (2012) Candidate gene studies of fibromyalgia: a systematic review and meta-analysis. Rheumatol Int 32:417–426Google Scholar
  97. Lehner B, Sandner B, Marschallinger J, Lehner C, Furtner T, Couillard-Despres S, Rivera FJ, Brockhoff G, Bauer HC, Weidner N, Aigner L (2011) The dark side of BrdU in neural stem cell biology: detrimental effects on cell cycle, differentiation and survival. Cell Tissue Res 345:313–328Google Scholar
  98. Leite-Almeida H, Almeida-Torres L, Mesquita AR, Pertovaara A, Sousa N, Cerqueira JJ, Almeida A (2009) The impact of age on emotional and cognitive behaviours triggered by experimental neuropathy in rats. Pain 144:57–65Google Scholar
  99. Leite-Almeida H, Cerqueira JJ, Wei H, Ribeiro-Costa N, Anjos-Martins H, Sousa N, Pertovaara A, Almeida A (2012) Differential effects of left/right neuropathy on rats’ anxiety and cognitive behavior. Pain 153:2218–2225Google Scholar
  100. Leite-Almeida H, Pinto-Ribeiro F, Almeida A (2015) Animal models for the study of comorbid pain and psychiatric disorders. Mod Trends Pharmacopsychiatry 30:1–21Google Scholar
  101. Lembo A, Zaman M, Jones M, Talley NJ (2007) Influence of genetics on irritable bowel syndrome, gastro-oesophageal reflux and dyspepsia: a twin study. Aliment Pharmacol Ther 25:1343–1350Google Scholar
  102. Lepine JP, Briley M (2004) The epidemiology of pain in depression. Hum Psychopharmacol 19(Suppl 1):S3–S7Google Scholar
  103. Leventhal L, Smith V, Hornby G, Andree TH, Brandt MR, Rogers KE (2007) Differential and synergistic effects of selective norepinephrine and serotonin reuptake inhibitors in rodent models of pain. J Pharmacol Exp Ther 320:1178–1185Google Scholar
  104. Li H, Xie H, Liu W, Hu R, Huang B, Tan YF, Xu K, Sheng ZF, Zhou HD, Wu XP, Luo XH (2009a) A novel microRNA targeting HDAC5 regulates osteoblast differentiation in mice and contributes to primary osteoporosis in humans. J Clin Invest 119:3666–3677Google Scholar
  105. Li TT, Ren WH, Xiao X, Nan J, Cheng LZ, Zhang XH, Zhao ZQ, Zhang YQ (2009b) NMDA NR2A and NR2B receptors in the rostral anterior cingulate cortex contribute to pain-related aversion in male rats. Pain 146:183–193Google Scholar
  106. Li Q, Yue N, Liu SB, Wang ZF, Mi WL, Jiang JW, Wu GC, Yu J, Wang YQ (2014) Effects of chronic electroacupuncture on depression-and anxiety-like behaviors in rats with chronic neuropathic pain. Evid Based Complement Alternat Med 2014:158987Google Scholar
  107. Li J, Li Y, Zhang B, Shen X, Zhao H (2016) Why depression and pain often coexist and mutually reinforce: role of the lateral habenula. Exp Neurol 284:106–113Google Scholar
  108. Li XM, Meng J, Li LT, Guo T, Yang LK, Shi QX, Li XB, Chen Y, Yang Q, Zhao JN (2017) Effect of ZBD-2 on chronic pain, depressive-like behaviors, and recovery of motor function following spinal cord injury in mice. Behav Brain Res 322:92–99Google Scholar
  109. Li T, Mamillapalli R, Ding S, Chang H, Liu ZW, Gao XB, Taylor HS (2018) Endometriosis alters brain electro-physiology, gene expression and increased pain sensitization, anxiety, and depression in female mice. Biol Reprod 99:349–359Google Scholar
  110. Liu MG, Chen J (2014) Preclinical research on pain comorbidity with affective disorders and cognitive deficits: challenges and perspectives. Prog Neurobiol 116:13–32Google Scholar
  111. Liu PK, Liu CH (2016) Epigenetics of amphetamine-induced sensitization: HDAC5 expression and microRNA in neural remodeling. J Biomed Sci 23:90Google Scholar
  112. Liu SB, Zhao R, Li XS, Guo HJ, Tian Z, Zhang N, Gao GD, Zhao MG (2014) Attenuation of reserpine-induced pain/depression dyad by gentiopicroside through downregulation of GluN2B receptors in the amygdala of mice. NeuroMolecular Med 16:350–359Google Scholar
  113. Liu D, Tang QQ, Yin C, Song Y, Liu Y, Yang JX, Liu H, Zhang YM, Wu SY, Song Y, Juarez B, Ding HL, Han MH, Zhang H, Cao JL (2018) Brain-derived neurotrophic factor-mediated projection-specific regulation of depressive-like and nociceptive behaviors in the mesolimbic reward circuitry. Pain 159:175Google Scholar
  114. Lomazzo E, Bindila L, Remmers F, Lerner R, Schwitter C, Hoheisel U, Lutz B (2015) Therapeutic potential of inhibitors of endocannabinoid degradation for the treatment of stress-related hyperalgesia in an animal model of chronic pain. Neuropsychopharmacol 40:488–501Google Scholar
  115. Lu CL, Herndon C (2017) New roles for neuronal estrogen receptors. Neurogastroenterol Motil 29.  https://doi.org/10.1111/nmo.13121
  116. Luongo L, de Novellis V, Gatta L, Palazzo E, Vita D, Guida F, Giordano C, Siniscalco D, Marabese I, De Chiaro M, Boccella S, Rossi F, Maione S (2013) Role of metabotropic glutamate receptor 1 in the basolateral amygdala-driven prefrontal cortical deactivation in inflammatory pain in the rat. Neuropharmacology 66:317–329Google Scholar
  117. M’Dahoma S, Barthélemy S, Tromilin C, Jeanson T, Viguier F, Michot B, Pezet S, Hamon M, Bourgoin S (2015) Respective pharmacological features of neuropathic-like pain evoked by intrathecal BDNF versus sciatic nerve ligation in rats. Eur Neuropsychopharmacol 25:2118–2130Google Scholar
  118. Maciel IS, Silva RB, Morrone FB, Calixto JB, Campos MM (2013) Synergistic effects of celecoxib and bupropion in a model of chronic inflammation-related depression in mice. PLoS One 8:e77227Google Scholar
  119. Magni G, Andreoli F, Arduino C, Arsie D, Ceccherelli F, Ambrosio F, Dodi G, Eandi M (1987) Modifications of [3H]imipramine binding sites in platelets of chronic pain patients treated with mianserin. Pain 30:311–320Google Scholar
  120. Masotti A, Baldassarre A, Guzzo MP, Iannuccelli C, Barbato C, Di Franco M (2017) Circulating microRNA profiles as liquid biopsies for the characterization and diagnosis of fibromyalgia syndrome. Mol Neurobiol 54:7129–7136Google Scholar
  121. Matosin N, Fernandez-Enright F, Frank E, Deng C, Wong J, Huang XF, Newell KA (2014) Metabotropic glutamate receptor mGluR2/3 and mGluR5 binding in the anterior cingulate cortex in psychotic and nonpsychotic depression, bipolar disorder and schizophrenia: implications for novel mGluR-based therapeutics. J Psychiatry Neurosci 39:407Google Scholar
  122. Matsuzawa-Yanagida K, Narita M, Nakajima M, Kuzumaki N, Niikura K, Nozaki H, Takagi T, Tamai E, Hareyama N, Terada M, Yamazaki M, Suzuki T (2007) Usefulness of antidepressants for improving the neuropathic pain-like state and pain-induced anxiety through actions at different brain sites. Neuropsychopharmacology 33:1952–1965Google Scholar
  123. Max MB, Wu T, Atlas SJ, Edwards RR, Haythornthwaite JA, Bollettino AF, Hipp HS, McKnight CD, Osman IA, Crawford EN, Pao M, Nejim J, Kingman A, Aisen DC, Scully MA, Keller RB, Goldman D, Belfer I (2006) A clinical genetic method to identify mechanisms by which pain causes depression and anxiety. Mol Pain 2:14Google Scholar
  124. McIntosh AM, Hall LS, Zeng Y, Adams MJ, Gibson J, Wigmore E, Hagenaars SP, Davies G, Fernandez-Pujals AM, Campbell AI, Clarke TK, Hayward C, Haley CS, Porteous DJ, Deary IJ, Smith DJ, Nicholl BI, Hinds DA, Jones AV, Scollen S, Meng W, Smith BH, Hocking LJ (2016) Genetic and environmental risk for chronic pain and the contribution of risk variants for major depressive disorder: a family-based mixed-model analysis. PLoS Med 13:e1002090Google Scholar
  125. Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR, Gopher A, Almog S, Martin BR, Compton DR et al (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50:83–90Google Scholar
  126. Miller AH, Maletic V, Raison CL (2009) Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 65:732–741Google Scholar
  127. Motaghinejad O, Motaghinejad M, Motevalian M, Rahimi-Sharbaf F, Beiranvand T (2017) The effect of maternal forced exercise on offspring pain perception, motor activity and anxiety disorder: the role of 5-HT2 and D2 receptors and CREB gene expression. J Exerc Rehabil 13:514–525Google Scholar
  128. Mutso AA, Radzicki D, Baliki MN, Huang L, Banisadr G, Centeno MV, Radulovic J, Martina M, Miller RJ, Apkarian AV (2012) Abnormalities in hippocampal functioning with persistent pain. J Neurosci 32:5747–5756Google Scholar
  129. Narita M, Kaneko C, Miyoshi K, Nagumo Y, Kuzumaki N, Nakajima M, Nanjo K, Matsuzawa K, Yamazaki M, Suzuki T (2006a) Chronic pain induces anxiety with concomitant changes in opioidergic function in the amygdala. Neuropsychopharmacology 31:739–750Google Scholar
  130. Narita M, Kuzumaki N, Narita M, Kaneko C, Hareyama N, Miyatake M, Shindo K, Miyoshi K, Nakajima M, Nagumo Y, Sato F, Wachi H, Seyama Y, Suzuki T (2006b) Chronic pain-induced emotional dysfunction is associated with astrogliosis due to cortical delta-opioid receptor dysfunction. J Neurochem 97:1369–1378Google Scholar
  131. Nasca C, Xenos D, Barone Y, Caruso A, Scaccianoce S, Matrisciano F, Battaglia G, Mathé AA, Pittaluga A, Lionetto L, Simmaco M, Nicoletti F (2013) L-acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors. Proc Natl Acad Sci U S A 110:4804–4809Google Scholar
  132. Nascimento FP, Macedo-Júnior SJ, Borges FR, Cremonese RP, da Silva MD, Luiz-Cerutti M, Martins DF, Rodrigues AL, Santos AR (2015) Thalidomide reduces mechanical hyperalgesia and depressive-like behavior induced by peripheral nerve crush in mice. Neuroscience 303:51–58Google Scholar
  133. Nielsen CK, Lewis RJ, Alewood D, Drinkwater R, Palant E, Patterson M, Yaksh TL, McCumber D, Smith MT (2005) Anti-allodynic efficacy of the chi-conopeptide, Xen2174, in rats with neuropathic pain. Pain 118:112–124Google Scholar
  134. Norman GJ, Karelina K, Morris JS, Zhang N, Cochran M, DeVries AC (2010a) Social interaction prevents the development of depressive-like behavior post nerve injury in mice: a potential role for oxytocin. Psychosom Med 72:519–526Google Scholar
  135. Norman GJ, Karelina K, Zhang N, Walton JC, Morris JS, Devries AC (2010b) Stress and IL-1β contribute to the development of depressive-like behavior following peripheral nerve injury. Mol Psychiatry 15:404Google Scholar
  136. Northoff G, Sibille E (2014) Why are cortical GABA neurons relevant to internal focus in depression? A cross-level model linking cellular, biochemical and neural network findings. Mol Psychiatry 19:966Google Scholar
  137. Orlova IA, Alexander GM, Qureshi RA, Sacan A, Graziano A, Barrett JE, Schwartzman RJ, Ajit SK (2011) MicroRNA modulation in complex regional pain syndrome. J Transl Med 9:195Google Scholar
  138. Pamuk ON, Cakir N (2007) The frequency of thyroid antibodies in fibromyalgia patients and their relationship with symptoms. Clin Rheumatol 26:55–59Google Scholar
  139. Pan W, Zhang GF, Li HH, Ji MH, Zhou ZQ, Li KY, Yang JJ (2018) Ketamine differentially restores diverse alterations of neuroligins in brain regions in a rat model of neuropathic pain-induced depression. Neuroreport 29:863Google Scholar
  140. Papp M, Klimek V, Willner P (1994) Parallel changes in dopamine D2 receptor binding in limbic forebrain associated with chronic mild stress-induced anhedonia and its reversal by imipramine. Psychopharmacology 115:441–446Google Scholar
  141. Pinheiro MB, Ferreira ML, Refshauge K, Colodro-Conde L, Carrillo E, Hopper JL, Ordoñana JR, Ferreira PH (2015) Genetics and the environment affect the relationship between depression and low back pain: a co-twin control study of Spanish twins. Pain 156:496–503Google Scholar
  142. Pinheiro MB, Morosoli JJ, Colodro-Conde L, Ferreira PH, Ordoñana JR (2018) Genetic and environmental influences to low back pain and symptoms of depression and anxiety: a population-based twin study. J Psychosom Res 105:92–98Google Scholar
  143. Pittenger C, Duman RS (2008) Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 33:88–109Google Scholar
  144. Pitzer C, La Porta C, Treede RD, Tappe-Theodor A (2019) Inflammatory and neuropathic pain conditions do not primarily evoke anxiety-like behaviours in C57BL/6 mice. Eur J Pain 23:285–306Google Scholar
  145. Pop VJ, Maartens LH, Leusink G, van Son MJ, Knottnerus AA, Ward AM, Metcalfe R, Weetman AP (1998) Are autoimmune thyroid dysfunction and depression related? J Clin Endocrinol Metab 83:3194–3197Google Scholar
  146. Qi WJ, Wang W, Wang N, Wang JY, Luo F (2013) Depressive-like history alters persistent pain behavior in rats: opposite contribution of frontal cortex and amygdala implied. Psych J 2:133–145Google Scholar
  147. Reckziegel D, Raschke F, Cottam WJ, Auer DP (2016) Cingulate GABA levels inversely correlate with the intensity of ongoing chronic knee osteoarthritis pain. Mol Pain 12.  https://doi.org/10.1177/1744806916650690
  148. Reichborn-Kjennerud T, Stoltenberg C, Tambs K, Roysamb E, Kringlen E, Torgersen S, Harris JR (2002) Back-neck pain and symptoms of anxiety and depression: a population-based twin study. Psychol Med 32:1009–1020Google Scholar
  149. Reyes-Gibby CC, Swartz MD, Yu X, Wu X, Yennurajalingam S, Anderson KO, Spitz MR, Shete S (2013) Symptom clusters of pain, depressed mood, and fatigue in lung cancer: assessing the role of cytokine genes. Support Care Cancer 21:3117–3125Google Scholar
  150. Ribeiro LS, Proietti FA (2004) Interrelations between fibromyalgia, thyroid autoantibodies, and depression. J Rheumatol 31:2036–2040Google Scholar
  151. Rodríguez-Gaztelumendi A, Rojo ML, Pazos A, Díaz Á (2014) An altered spinal serotonergic system contributes to increase thermal nociception in an animal model of depression. Exp Brain Res 232:1793–1803Google Scholar
  152. Roeska K, Doods H, Arndt K, Treede RD, Ceci A (2008) Anxiety-like behaviour in rats with mononeuropathy is reduced by the analgesic drugs morphine and gabapentin. Pain 139:349–357Google Scholar
  153. Romero-Grimaldi C, Berrocoso E, Alba-Delgado C, Madrigal JL, Perez-Nievas BG, Leza JC, Mico JA (2015) Stress increases the negative effects of chronic pain on hippocampal neurogenesis. Anesth Analg 121:1078–1088Google Scholar
  154. Sagheddu C, Aroni S, De Felice M, Lecca S, Luchicchi A, Melis M, Muntoni AL, Romano R, Palazzo E, Guida F, Maione S, Pistis M (2015) Enhanced serotonin and mesolimbic dopamine transmissions in a rat model of neuropathic pain. Neuropharmacology 97:383–393Google Scholar
  155. Sawada A, Niiyama Y, Ataka K, Nagaishi K, Yamakage M, Fujimiya M (2014) Suppression of bone marrow-derived microglia in the amygdala improves anxiety-like behavior induced by chronic partial sciatic nerve ligation in mice. Pain 155:1762–1772Google Scholar
  156. Schroeder M, Krebs MO, Bleich S, Frieling H (2010) Epigenetics and depression: current challenges and new therapeutic options. Curr Opin Psychiatry 23:588–592Google Scholar
  157. Sellmeijer J, Mathis V, Hugel S, Li XH, Song Q, Chen QY, Barthas F, Lutz PE, Karatas M, Luthi A, Veinante P, Aertsen A, Barrot M, Zhuo M, Yalcin I (2018) Hyperactivity of anterior cingulate cortex areas 24a/24b drives chronic pain-induced anxiodepressive-like consequences. J Neurosci 38:3102–3115Google Scholar
  158. Simon GE (2003) Social and economic burden of mood disorders. Biol Psychiatry 54:208–215Google Scholar
  159. Skrabek RQ, Galimova L, Ethans K, Perry D (2008) Nabilone for the treatment of pain in fibromyalgia. J Pain 9:164–173Google Scholar
  160. Sorkin LS, Yaksh TL (2009) Behavioral models of pain states evoked by physical injury to the peripheral nerve. Neurotherapeutics 6:609–619Google Scholar
  161. Stoy M, Schlagenhauf F, Sterzer P, Bermpohl F, Hägele C, Suchotzki K, Schmack K, Wrase J, Ricken R, Knutson B, Adli M, Bauer M, Heinz A, Ströhle A (2012) Hyporeactivity of ventral striatum towards incentive stimuli in unmedicated depressed patients normalizes after treatment with escitalopram. J Psychopharmacol 26:677–688Google Scholar
  162. Stratinaki M, Varidaki A, Mitsi V, Ghose S, Magida J, Dias C, Russo SJ, Vialou V, Caldarone BJ, Tamminga CA, Nestler EJ, Zachariou V (2013) Regulator of G protein signaling is a crucial modulator of antidepressant drug action in depression and neuropathic pain models. Proc Natl Acad Sci U S A 110:8254–8259Google Scholar
  163. Su C, D’amour J, Lee M, Lin HY, Manders T, Xu D, Eberle SE, Goffer Y, Zou AH, Rahman M, Ziff E, Froemke RC, Huang D, Wang J (2015) Persistent pain alters AMPA receptor subunit levels in the nucleus accumbens. Mol Brain 8:46Google Scholar
  164. Suzuki T, Amata M, Sakaue G, Nishimura S, Inoue T, Shibata M, Mashimo T (2007) Experimental neuropathy in mice is associated with delayed behavioral changes related to anxiety and depression. Anesth Analg 104:1570–1577Google Scholar
  165. Tateiwa H, Kawano T, Nishigaki A, Yamanaka D, Aoyama B, Shigematsu-Locatelli M, Eguchi S, Locatelli FM, Yokoyama M (2018) The role of hippocampal brain-derived neurotrophic factor in age-related differences in neuropathic pain behavior in rats. Life Sci 197:56–66Google Scholar
  166. Tran L, Chaloner A, Sawalha AH, Greenwood-Van Meerveld B (2013) Importance of epigenetic mechanisms in visceral pain induced by chronic water avoidance stress. Psychoneuroendocrinology 38:898–906Google Scholar
  167. Tran L, Schulkin J, Ligon CO, Greenwood-Van Meerveld B (2014) Epigenetic modulation of chronic anxiety and pain by histone deacetylation. Mol Psychiatry 20:1219–1231Google Scholar
  168. Ulrich-Lai YM, Xie W, Meij JT, Dolgas CM, Yu L, Herman JP (2006) Limbic and HPA axis function in an animal model of chronic neuropathic pain. Physiol Behav 88:67–76Google Scholar
  169. Urban R, Scherrer G, Goulding EH, Tecott LH, Basbaum A (2011) Behavioral indices of ongoing pain are largely unchanged in male mice with tissue or nerve injury-induced mechanical hypersensitivity. Pain 152:990–1000Google Scholar
  170. van Riezen H, Leonard BE (1990) Effects of psychotropic drugs on the behavior and neurochemistry of olfactory bulbectomized rats. Pharmacol Ther 47:21–34Google Scholar
  171. Vinod KY, Xie S, Psychoyos D, Hungund BL, Cooper TB, TejaniButt SM (2012) Dysfunction in fatty acid amide hydrolase is associated with depressive-like behavior in Wistar Kyoto rats. PLoS One 7:e36743Google Scholar
  172. Wallace VC, Blackbeard J, Pheby T, Segerdahl AR, Davies M, Hasnie F, Hall S, McMahon SB, Rice AS (2007) Pharmacological, behavioural and mechanistic analysis of HIV-1 gp120 induced painful neuropathy. Pain 133:47–63Google Scholar
  173. Wang J, Goffer Y, Xu D, Tukey DS, Shamir DB, Eberle SE, Zou AH, Blanck TJJ, Ziff EB (2011) A single sub-anesthetic dose of ketamine relieves depression-like behaviors induced by neuropathic pain in rats. Anesthesiology 115:812–821Google Scholar
  174. Wang GQ, Cen C, Li C, Cao S, Wang N, Zhou Z, Liu XM, Xu Y, Tian NX, Zhang Y, Wang J, Wang LP, Wang Y (2015) Deactivation of excitatory neurons in the prelimbic cortex via Cdk5 promotes pain sensation and anxiety. Nat Commun 6:7660Google Scholar
  175. Wang W, Li C, Cai Y, Pan ZZ (2017) Pain vulnerability and DNA methyltransferase 3a involved in the affective dimension of chronic pain. Mol Pain 13:1–12Google Scholar
  176. Wei X, Sun Y, Luo F (2017) Impaired spinal glucocorticoid receptor signaling contributes to the attenuating effect of depression on mechanical allodynia and thermal hyperalgesia in rats with neuropathic pain. Front Cell Neurosci 11:145Google Scholar
  177. White RE, Giffard RG (2012) MicroRNA-320 induces neurite outgrowth by targeting ARPP-19. Neuroreport 23:590–595Google Scholar
  178. Whiteside GT, Dwyer JM, Harrison JE, Beyer CE, Cummons T, Manzino L, Mark L, Johnston GH, Strassle BW, Adedoyin A, Lu P, Piesla MJ, Pulicicchio CM, Erve JC, Platt BJ, Hughes ZA, Rogers KE, Deecher DC, Trybulski EJ, Kennedy JD, Zhang P, Leventhal L (2010) WAY-318068: a novel, potent and selective noradrenaline re-uptake inhibitor with activity in rodent models of pain and depression. Br J Pharmacol 160:1105–1118Google Scholar
  179. Woolridge E, Barton S, Samuel J, Osorio J, Dougherty A, Holdcroft A (2005) Cannabis use in HIV for pain and other medical symptoms. J Pain Symptom Manag 29:358–367Google Scholar
  180. World Health Organization (2008) The global burden of disease: 2004 update World Health Organization, GenevaGoogle Scholar
  181. Wu J, Zhao Z, Sabirzhanov B, Stoica BA, Kumar A, Luo T, Skovira J, Faden AI (2014) Spinal cord injury causes brain inflammation associated with cognitive and affective changes: role of cell cycle pathways. J Neurosci 34:10989–11006Google Scholar
  182. Xie JY, Qu C, Patwardhan A, Ossipov MH, Navratilova E, Becerra L, Borsook D, Porreca F (2014) Activation of mesocorticolimbic reward circuits for assessment of relief of ongoing pain: a potential biomarker of efficacy. Pain 155:1659–1666Google Scholar
  183. Xie ZM, Wang XM, Xu N, Wang J, Pan W, Tang XH, Zhou ZQ, Hashimoto K, Yang JJ (2017) Alterations in the inflammatory cytokines and brain-derived neurotrophic factor contribute to depression-like phenotype after spared nerve injury: improvement by ketamine. Sci Rep 7:3124Google Scholar
  184. Xu Y, Zhang L, Shao T, Ruan L, Wang L, Sun J, Li J, Zhu X, O’Donnell JM, Pan J (2013) Ferulic acid increases pain threshold and ameliorates depression-like behaviors in reserpine-treated mice: behavioral and neurobiological analyses. Metab Brain Dis 28:571–583Google Scholar
  185. Yalcin I, Tessier LH, Petit-Demouliere N, Doridot S, Hein L, Freund-Mercier MJ, Barrot M (2009) Beta2-adrenoceptors are essential for desipramine, venlafaxine or reboxetine action in neuropathic pain. Neurobiol Dis 33:386–394Google Scholar
  186. Yalcin I, Bohren Y, Waltisperger E, Sage-Ciocca D, Yin JC, Freund-Mercier MJ, Barrot M (2011) A time-dependent history of mood disorders in a murine model of neuropathic pain. Biol Psychiatry 70:946–953Google Scholar
  187. Yalcin I, Barthas F, Barrot M (2014) Emotional consequences of neuropathic pain: insight from preclinical studies. Neurosci Biobehav Rev 47:154–164Google Scholar
  188. Yasuda S, Yoshida M, Yamagata H, Iwanaga Y, Suenaga H, Ishikawa K, Nakano M, Okuyama S, Furukawa Y, Furukawa S, Ishikawa T (2014) Imipramine ameliorates pain-related negative emotion via induction of brain-derived neurotrophic factor. Cell Mol Neurobiol 34:1199–1208Google Scholar
  189. Yu YB, Zuo XL, Zhao QJ, Chen FX, Yang J, Dong YY, Wang P, Li YQ (2011) Brain-derived neurotrophic factor contributes to abdominal pain in irritable bowel syndrome. Gut 61:685–694Google Scholar
  190. Zarate C, Machado-Vieira R, Henter I, Ibrahim L, Diazgranados N, Salvadore G (2010) Glutamatergic modulators: the future of treating mood disorders? Harv Rev Psychiatry 18:293–303Google Scholar
  191. Zeng Q, Wang S, Lim G, Yang L, Mao J, Sung B, Chang Y, Lim JA, Guo G, Mao J (2008) Exacerbated mechanical allodynia in rats with depression-like behavior. Brain Res 1200:27–38Google Scholar
  192. Zhang MM, Liu SB, Chen T, Koga K, Zhang T, Li YQ, Zhuo M (2014) Effects of NB001 and gabapentin on irritable bowel syndrome-induced behavioral anxiety and spontaneous pain. Mol Brain 7:47Google Scholar
  193. Zhang Z, Gadotti VM, Chen L, Souza IA, Stemkowski PL, Zamponi GW (2015) Role of prelimbic GABAergic circuits in sensory and emotional aspects of neuropathic pain. Cell Rep 12:752–759Google Scholar
  194. Zhang GF, Wang J, Han JF, Guo J, Xie ZM, Pan W, Yang JJ, Sun KJ (2016a) Acute single dose of ketamine relieves mechanical allodynia and consequent depression-like behaviors in a rat model. Neurosci Lett 631:7–12Google Scholar
  195. Zhang L, Wang G, Ma J, Liu C, Liu X, Zhan Y, Zhang M (2016b) Brain-derived neurotrophic factor (BDNF) in the rostral anterior cingulate cortex (rACC) contributes to neuropathic spontaneous pain-related aversion via NR2B receptors. Brain Res Bull 127:56–65Google Scholar
  196. Zhang M, Liu Y, Zhao M, Tang W, Wang X, Dong Z, Yu S (2017) Depression and anxiety behaviour in a rat model of chronic migraine. J Headache Pain 18:27Google Scholar
  197. Zhao J, Seereeram A, Nassar MA, Levato A, Pezet S, Hathaway G, Morenilla-Palao C, Stirling C, Fitzgerald M, McMahon SB, Rios M, Wood JN (2006a) Nociceptor-derived brain-derived neurotrophic factor regulates acute and inflammatory but not neuropathic pain. Mol Cell Neurosci 31:539–548Google Scholar
  198. Zhao MG, Ko SW, Wu LJ, Toyoda H, Xu H, Quan J, Li J, Jia Y, Ren M, Xu ZC, Zhuo M (2006b) Enhanced presynaptic neurotransmitter release in the anterior cingulate cortex of mice with chronic pain. J Neurosci 26:8923–8930Google Scholar
  199. Zhao ZQ, Chiechio S, Sun YG, Zhang KH, Zhao CS, Scott M, Johnson RL, Deneris ES, Renner KJ, Gereau RW 4th, Chen ZF (2007) Mice lacking central serotonergic neurons show enhanced inflammatory pain and an impaired analgesic response to antidepressant drugs. J Neurosci 27:6045–6053Google Scholar
  200. Zhao X, Wang C, Zhang JF, Liu L, Liu AM, Ma Q, Zhou WH, Xu Y (2014a) Chronic curcumin treatment normalizes depression-like behaviors in mice with mononeuropathy: involvement of supraspinal serotonergic system and GABAA receptor. Psychopharmacology 231:2171–2187Google Scholar
  201. Zhao X, Yu C, Wang C, Zhang JF, Zhou WH, Cui WG, Ye F, Xu Y (2014b) Chronic resveratrol treatment exerts antihyperalgesic effect and corrects co-morbid depressive like behaviors in mice with mononeuropathy: involvement of serotonergic system. Neuropharmacology 85:131–141Google Scholar
  202. Zhao J, Luo D, Liang Z, Lao L, Rong J (2017) Plant natural product puerarin ameliorates depressive behaviors and chronic pain in mice with spared nerve injury (SNI). Mol Neurobiol 54:2801–2812Google Scholar
  203. Zheng J, Jiang YY, Xu LC, Ma LY, Liu FY, Cui S, Cai J, Liao FF, Wan Y, Yi M (2017) Adult hippocampal neurogenesis along the dorsoventral axis contributes differentially to environmental enrichment combined with voluntary exercise in alleviating chronic inflammatory pain in mice. J Neurosci 37:4145–4157Google Scholar
  204. Zhao J, Luo D, Liang Z, Lao L, Rong J (2017) Plant Natural Product Puerarin Ameliorates Depressive Behaviors and Chronic Pain in Mice with Spared Nerve Injury (SNI). Mol Neurobiol 54:2801–2812Google Scholar
  205. Zhou W, Dantzer R, Budac DP, Walker AK, Mao-Ying QL, Lee AW, Heijnen CJ, Kavelaars A (2015) Peripheral indoleamine 2, 3-dioxygenase 1 is required for comorbid depression-like behavior but does not contribute to neuropathic pain in mice. Brain Behav Immun 46:147–153Google Scholar
  206. Zhu C, Xu Q, Wang C, Mao Z, Lin N (2017) Evidence that CA3 is underling the comorbidity between pain and depression and the co-curation by Wu-Tou decoction in neuropathic pain. Sci Rep 7:11935Google Scholar
  207. Zhuo M (2016) Neural mechanisms underlying anxiety–chronic pain interactions. Trends Neurosci 39:136–145Google Scholar
  208. Zorumski CF, Izumi Y, Mennerick S (2016) Ketamine: NMDA receptors and beyond. J Neurosci 36:11158–11164Google Scholar
  209. Zussy C, Gómez-Santacana X, Rovira X, De Bundel D, Ferrazzo S, Bosch D, Asede D, Malhaire F, Acher F, Giraldo J, Valjent E, Ehrlich I, Ferraguti F, Pin JP, Llebaria A, Goudet C (2016) Dynamic modulation of inflammatory pain-related affective and sensory symptoms by optical control of amygdala metabotropic glutamate receptor 4. Mol Psychiatry 23:509–520Google Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Institut des Neurosciences Cellulaires et Intégratives, Centre National de la Recherche Scientifique et Université de StrasbourgStrasbourgFrance
  2. 2.Faculty of Biology and Bernstein Center FreiburgUniversity of FreiburgFreiburgGermany

Personalised recommendations